Cargando…
The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders
Imaging biomarkers play a wide-ranging role in clinical trials for neurological disorders. This includes selecting the appropriate trial participants, establishing target engagement and mechanism-related pharmacodynamic effect, monitoring safety, and providing evidence of disease modification. In th...
Autor principal: | Schwarz, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423963/ https://www.ncbi.nlm.nih.gov/pubmed/33846962 http://dx.doi.org/10.1007/s13311-021-01027-4 |
Ejemplares similares
-
NADPH oxidase in brain injury and neurodegenerative disorders
por: Ma, Merry W., et al.
Publicado: (2017) -
Brain-Derived Neurotropic Factor in Neurodegenerative Disorders
por: Ibrahim, Abdallah Mohammad, et al.
Publicado: (2022) -
Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism
por: Brooks, David J.
Publicado: (2021) -
Standardizing liver imaging reporting and interpretation: LI-RADS and beyond
por: Rich, Nicole E., et al.
Publicado: (2023) -
The role of basket trials in drug development for neurodegenerative disorders
por: Cummings, Jeffrey, et al.
Publicado: (2022)